Abstract
Pituitary apoplexy (haemorrhage or infarction) usually occurs in patients, who were not previously diagnosed to have pituitary adenomas. There are conflicting reports on the commonest types of tumour responsible for apoplexy. Some studies have shown predominance of non-functional adenomas, other studies have reported higher prevalence in functioning adenomas among which prolactinomas have the highest risk, and other studies have shown equal prevalence among functioning and non-functioning tumours. Prospective follow-up studies have reported the occurrence of pituitary apoplexy in previously diagnosed non-functioning pituitary adenomas. Several retrospective studies have reported occurrence of pituitary apoplexy among patients with previously diagnosed functioning as well non-functioning tumours. Pituitary apoplexy has been reported as early as 6 months to as late as 18 years after the diagnosis of functioning tumours. Resolution of hormonal hypersecretion in previously known functional tumours has also been reported in some studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ACTH:
-
Adrenocorticotropic hormone
- CRH:
-
Corticotropin hormone
- Gd-DTPA:
-
Gadolinium-diethylenetriaminepentaacetic acid
- GH:
-
Growth hormone
- GnRH:
-
Gonadotropin-releasing hormone
- MRI:
-
Magnetic resonance imaging
- PRL:
-
Prolactin
- TRH:
-
Thyrotropin-releasing hormone
References
Acikgoz B, Cagavi F, Tekkok HI. Late recurrent bleeding after surgical treatment for pituitary apoplexy. J Clin Neurosci. 2004;11:555–9.
Ahmad FU, Pandey P, Mahapatra AK. Post-operative ‘pituitary apoplexy’ in giant pituitary adenomas: a series of cases. Neurol India. 2005;53:326–8.
Arafah BM, Taylor HC, Salazar R, Saadi H, Selman WR. Apoplexy of a pituitary adenoma after dynamic testing with gonadotropin-releasing hormone. Am J Med. 1989;87:103–5.
Arita K, Tominaga A, Sugiyama K, Eguchi K, Iida K, Sumida M, Migita K, Kurisu K. Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination. J Neurosurg. 2006;104:884–91.
Balarini Lima GA, Machado Ede O, Dos Santos Silva CM, Filho PN, Gadelha MR. Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline. Pituitary. 2008;11:287–92.
Bernstein M, Hegele RA, Gentili F, Brothers M, Holgate R, Sturtridge WC, Deck J. Pituitary apoplexy associated with a triple bolus test. Case report. J Neurosurg. 1984;61:586–90.
Bills DC, Meyer FB, Laws Jr ER, Davis DH, Ebersold MJ, Scheithauer BW, Ilstrup DM, Abboud CF. A retrospective analysis of pituitary apoplexy. Neurosurgery. 1993;33:602–9.
Biousse V, Newman NJ, Oyesiku NM. Precipitating factors in pituitary apoplexy. J Neurol Neurosurg Psychiatry. 2001;71:542–5.
Bonicki W, Kasperlik-Zaluska A, Koszewski W, Zgliczyński W, Wisławski J. Pituitary apoplexy: endocrine, surgical and oncological emergency. Incidence, clinical course and treatment with reference to 799 cases of pituitary adenomas. Acta Neurochir (Wien). 1993;120:118–22.
Chen L, White WL, Spetzler RF, Xu B. A prospective study of nonfunctioning pituitary adenomas: presentation, management, and clinical outcome. J Neurooncol. 2011;102:129–38.
Dokmetas HS, Selcuklu A, Colak R, Unlühizarci K, Bayram F, Keleştimur F. Pituitary apoplexy probably due to TRH and GnRH stimulation tests in a patient with acromegaly. J Endocrinol Invest. 1999;22:698–700.
Dubuisson AS, Beckers A, Stevenaert A. Classical pituitary tumour apoplexy: clinical features, management and outcomes in a series of 24 patients. Clin Neurol Neurosurg. 2007;109:63–70.
Goel A, Deogaonkar M, Deasi K. Fatal postoperative pituitary apoplexy: its cause and management. Br J Neurosurg. 1995;9:37–40.
Hiroi N, Ichuo T, Shimojo M, Ueshiba H, Tsuboi K, Miyachi Y. Pituitary apoplexy caused by luteinizing hormone-releasing hormone in prolactin-producing adenoma. Intern Med. 2001;40:747–50.
Imboden PNE, Tribolet ND, Lobrinus A, Gaillard RC, Portmann L, Pralong F, Gomez F. Apoplexy in pituitary macroadenoma. Medicine. 2005;84:188–96.
Kilicli F, Dökmetaş HS, Gürelik M. Development of pituitary apoplexy during TRH/GnRH test in a patient with pituitary macroadenoma. Singapore Med J. 2010;51:e179–81.
Knoepfelmacher M, Gomes MC, Melo ME, Mendonca BB. Pituitary apoplexy during therapy with cabergoline in an adolescent male with prolactin-secreting macroadenoma. Pituitary. 2004;7:83–7.
Korsic M, Lelas-Bahun N, Surdonja P, Besenski N, Horvat S, Plavsić V. Infarction of FSH-secreting pituitary adenoma. Acta Endocrinol (Copenh). 1984;107:149–54.
Lee DH, Chung MY, Chung DJ, Kim JM, Lee TH, Nam JH, Park CS. Apoplexy of pituitary macroadenoma after combined test of anterior pituitary function. Endocr J. 2000;47(3):329–33.
Leyer C, Castinetti F, Morange I, Gueydan M, Oliver C, Conte-Devolx B, Dufour H, Brue T. A conservative management is preferable in milder forms of pituitary tumor apoplexy. J Endocrinol Invest. 2011;34:502–9.
Louwerens M, de Herder WW, Postema PTE, Tanghe HL, Lamberts SW. Pituitary insufficiency and regression of acromegaly caused by pituitary followed cerebral angiography. Eur J Endocrinol. 1996;134:737–40.
Lubina A, Olchovsky D, Berezin M, Ram Z, Hadani M, Shimon I. Management of pituitary apoplexy: clinical experience with 40 patients. Acta Neurochir (Wien). 2005;147:151–7.
Masago A, Ueda Y, Kanai H, Nagai H, Umemura S. Pituitary apoplexy after pituitary function test: a report of two cases and review of the literature. Surg Neurol. 1995;43:158–64.
Masson EA, Atkin SL, Diver M, White MC. Pituitary apoplexy and sudden blindness following the administration of gonadotrophin releasing hormone. Clin Endocrinol (Oxf). 1993;38:109–10.
Matsuura I, Saeki N, Kubota M, Murai H, Yamaura A. Infarction followed by haemorrhage in pituitary adenoma due to endocrine stimulation test. Endocr J. 2001;48:493–8.
Mohr G, Hardy J. Haemorrhage, necrosis and apoplexy in pituitary adenomas. Surg Neurol. 1982;18:181–9.
Moller-Goede DL, Brandle M, Landau K, Bernays RL, Schmid C. Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome. Eur J Endocrinol. 2011;164:37–43.
Nielsen EH, Lindholm J, Bjerre P, Christiansen JS, Hagen C, Juul S, Jørgensen J, Kruse A, Laurberg P. Frequent occurrence of pituitary apoplexy in patients with non-functioning pituitary adenoma. Clin Endocrinol (Oxf). 2006;64:319–22.
Okuda O, Umezawa H, Miyaoka M. Pituitary apoplexy caused by endocrine stimulation tests: a case report. Surg Neurol. 1994;42:19–22.
Onesti ST, Wisniewski T, Post KD. Clinical versus subclinical pituitary apoplexy: presentation, surgical management and outcome in 21 patients. Neurosurgery. 1990;26:980–6.
Pelkonen R, Kuusisto A, Salmi J, Eistola P, Raitta C, Karonen SL, Aro A. Pituitary function after pituitary apoplexy. Am J Med. 1978;65:773–8.
Pinto G, Zerah M, Trivin C, Brauner R. Pituitary apoplexy in an adolescent with prolactin-secreting adenoma. Horm Res. 1998;50:38–41.
Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CB, Wass JA. Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxf). 1999;51:181–8.
Rotman-Pikielny P, Patronas N, Papanicolaou DA. Pituitary apoplexy induced by corticotrophin-releasing hormone in a patient with Cushing’s disease. Clin Endocrinol (Oxf). 2003;58:545–9.
Sachdev Y, Gopal K, Garg VK, Mongia SS. Pituitary apoplexy (spontaneous pituitary necrosis). Postgrad Med J. 1981;57:289–93.
Schatz NJ, Job OM, Glaser JS. Spontaneous resolution of pituitary adenoma after apoplexy. J Neuroophthalmol. 2000;20:42–4.
Semple PL, Jane Jr JA, Laws Jr ER. Clinical relevance of precipitating factors in pituitary apoplexy. Neurosurgery. 2007;61:956–62.
Sibal L, Ball SG, Connolly V, James RA, Kane P, Kelly WF, Kendall-Taylor P, Mathias D, Perros P, Quinton R, Vaidya B. Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases. Pituitary. 2004;7:157–63.
Szabolcs I, Kesmarki N, Bor K, Czirják S, Dohán O, Slovik F, Góth M, Kovács L, Ferencz A, Rimanóczy E, Szilágyi G. Apoplexy of a pituitary macroadenoma as a severe complication of preoperative thyrotropin-releasing hormone (TRH) testing. Exp Clin Endocrinol Diabetes. 1997;105:234–6.
Wakai S, Fukushima T, Teramoto A, Sano K. Pituitary apoplexy: its incidence and clinical significance. J Neurosurg. 1981;55:187–93.
Walker AB, Eldridge PR, MacFarlane IA. Clomiphene-induced pituitary apoplexy in a patient with acromegaly. Postgrad Med J. 1996;72:172–82.
Wang HF, Huang CC, Chen YF, Ho DM, Lin HD. Pituitary apoplexy after thyrotropin-releasing hormone stimulation test in a patient with pituitary macroadenoma. J Chin Med Assoc. 2007;70:392–5.
White MC, Masson EA. Pituitary apoplexy following the administration of gonadotropin releasing hormone. Clin Endocrinol. 1994;41:696–7.
Wichers M, Kristof RA, Springer W, Schramm J, Klingmüller D. Pituitary apoplexy with spontaneous cure of acromegaly and its possible relation to Gd-DTPA administration. Acta Neurochir (Wien). 1997;139:992–4.
Yoshino A, Katayama Y, Watanabe T, Ogino A, Ohta T, Komine C, Yokoyama T, Fukushima T, Hirota H. Apoplexy accompanying pituitary adenoma as a complication of pre-operative anterior pituitary function tests. Acta Neurochir (Wein). 2007;149:557–65.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Salam, R., Baruah, M.P. (2014). Apoplexy in Previously Known Tumours. In: Turgut, M., Mahapatra, A., Powell, M., Muthukumar, N. (eds) Pituitary Apoplexy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-38508-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-38508-7_5
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-38507-0
Online ISBN: 978-3-642-38508-7
eBook Packages: MedicineMedicine (R0)